Skip to content

Other

Gallamine triethiodide (INN)

CAS 65-29-2
8

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

Gallamine triethiodide (INN) is a cosmetic ingredient used in product formulations. Its specific function may vary between products. Exercise caution due to limited available safety data.

Gallamine Triethiodide (INN) is a synthetic non-depolarizing muscle relaxant (curariform) drug used in anesthesia and critical care medicine. It functions as a competitive antagonist at nicotinic acetylcholine receptors, causing skeletal muscle paralysis. It is subject to prescription drug controls in most jurisdictions and has no cosmetic application whatsoever. Its hazard statements include H302 (harmful if swallowed), H315 (skin irritation), H319 (serious eye irritation), and H335 (may cause respiratory irritation), consistent with its pharmacological action as a muscle-acting compound. Under EU Regulation 1223/2009, this compound would not appear on any authorized cosmetic ingredient list and represents a complete regulatory anomaly.

Known concerns

  • H302 — Harmful if swallowed
  • H315 — Causes skin irritation
  • H319 — Causes serious eye irritation
  • H335 — May cause respiratory irritation
  • Pharmacological muscle relaxant drug — not a cosmetic ingredient
  • Subject to drug regulatory controls, not cosmetic regulations

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

Check your shelf

Find Gallamine triethiodide (INN) in your products.

Scan any cosmetic product with LuxSense to see if it contains Gallamine triethiodide (INN) and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.